source
- Novartis' radioligand therapy Lutathera could soon face generic competitionThe radioligand field is on the cusp of a major competitive moment, as a rival looks to bring the first generic to a market that’s been dominated by Novartis. Radioligand therapy aims to bring the ...Endpoints · 4mo ago↗ source
- STAT+: Legislatures in Colorado and Virginia resist moves to constrain drug affordability boardsLegislators in two states are resisting efforts to restrict prescription drug affordability boards.STAT · 4mo ago↗ source
- Opinion: Dropping the flu vaccine requirement puts U.S. military readiness at riskSince the 1918 pandemic, the military has acknowledged the threat of influenza. Now that’s changing.STAT · 4mo ago↗ source